Crystal Flush Launches an Informative e-Book on Toenail Fungus

With approximately 35 million people in the United States affected by toenail fungal infection, the Antifungal brand, Crystal Flush, reminds them of the potential dangers of ignoring it in a newly published e-Book.

Dallas, Texas--(Newsfile Corp. - November 24, 2021) - Crystal Flush, a doctor-endorsed antifungal brand, has recently launched its informational eBook entitled "The 7 Dangers of Ignoring Toe Fungus." The 21-page eBook details the potential dangers toenail fungus may cause if left untreated for a long time.

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8033/104929_cd0349b254648a53_001full.jpg

With approximately 35 million people in the country suffering from toenail fungal infection, Crystal Flush created the informational eBook to provide everything they need to know about toenail fungus.

We believe that knowledge is power, and you have to understand what youre up against to fight this condition, Crystal Flush wrote. Research has shown that this fungus doesnt stop with your nails. It can spread to other parts of your body and cause further issues.

Crystal Flush pointed out that the whole eBook is not medical advice and encouraged readers to seek consultation from their doctors for any health-related questions.

About Crystal Flush

Crystal Flush is a full treatment system targeting external and internal causes of onychomycosis.

Crystal Flushs 2-step treatment system, containing a clinically proven FDA-Approved active ingredient, is the only toe fungus treatment available that targets both external and internal causes of toe fungus.

Media Contact:

https://www.crystalflush.com/

[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104929

You May Also Be Interested In

• ALX Resources Corp. Intersects Additional Uranium Mineralization at the Gibbons Creek Uranium Project, Athabasca Basin, Saskatchewan
• LFL Announces Date for 2024 First Quarter Financial Results Release
• Kura Oncology to Report First Quarter 2024 Financial Results